The Retina Group of Washington is currently enrolling patients for the following major Clinical Trials (diseases in parentheses):

Fairfax, VA

Alexion- Danicopan (Geographic Atrophy Secondary to Age-Related Macular Degeneration)
Coast – OPT-302 with Aflibercept (Neovascular Age-related Macular Degeneration)
Notal Vision Home OCT Study – Evaluation of Repeated, In Clinic, Self-Imaging (Diabetic Macular Edema)

Chevy Chase, MD

Parasol/ Janssen- JNJ-81201887 Compared to Sham (Geographic Atrophy Secondary to Age-related Macular Degeneration) 

The Retina Group of Washington is currently actively participating but no longer enrolling in the following major Clinical Trials (diseases in parenthesis):


Chevy Chase, MD

Alkeus/ SAGA – ALK-001 (Geographic Atrophy)
Apellis Gale – Extension Study to Evaluate Long-term Safety and Efficacy of Pegcetacoplan (Geographic Atrophy Secondary to Age Related Macular Degeneration)
Avonelle-X – Extension to Evaluate the Long-Term Safety and Tolerability of Faricimab (Neovascular Age-Related Macular Degeneration)
Comino – Study to evaluate the efficacy and Safety of Faricimab (Central Retinal or Hemiretinal Vein Occlusion
Gather 2 ISEE2008 – Zimura Compared to Sham(Geographic Atrophy)
Gather 2 OLE ISEE2009 – Open-Label Extension for Avacincaptad (Geographic Atrophy)
Pagoda – Port Delivery System with Ranibizumab (Diabetic Macular Edema)
Portal- Extension Study for Port Delivery System with Ranibizumab (Neovascular Age-Related Macular Degeneration) 

Sub-Studies
Ulcerative Colitis (Capital Digestive) 

Fairfax, VA

Alkeus/ SAGA - ALK-001 (Geographic Atrophy)
Apellis Gale - Extension Study to Evaluate Long-term Safety and Efficacy of Pegcetacoplan (Geographic Atrophy Secondary to Age Related Macular Degeneration)
Eyepoint – EYP-1901 (Wet Age-Related Macular Degeneration)

Sub-Studies
Next Oncology
Virginia Cancer Specialists